Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenhua Hu

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Analytical Chemistry|July 31, 2023
Novel Approach to Enriching Glycosylated RNAs: Specific Capture of GlycoRNAs via Solid-Phase ChemistryJiajia Li, Shuang Yue, Ziyuan Gao, et al.
Antiviral Therapy|January 24, 2014
A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infectionFumitaka Suzuki, Joji Toyota, Kenji Ikeda, et al.
Antiviral Therapy|January 24, 2014
Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 22, 2013
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis BRobert Perrillo, Maria Buti, Francois Durand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
A practical method to calibrate self-reported adherence to antiretroviral therapyHonghu Liu, Loren G Miller, Ron D Hays, et al.
Journal of Hepatology|November 28, 2012
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment optionsYoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, et al.
Science Bulletin|April 2, 2025
Intrinsic ion migration-induced susceptible two-dimensional phase-transition memristor with ultralow power consumptionLanhao Qin, Yimeng Yu, Cheng Fang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 19, 2024
Intrinsic Defect-Driven Synergistic Synaptic Heterostructures for Gate-Free Neuromorphic PhototransistorsYao Deng, Shenghong Liu, Xiaoxi Ma, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patientsHiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology|August 10, 2016
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infectionJoji Toyota, Yoshiyasu Karino, Fumitaka Suzuki, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Analytical Chemistry|July 31, 2023
Novel Approach to Enriching Glycosylated RNAs: Specific Capture of GlycoRNAs via Solid-Phase ChemistryJiajia Li, Shuang Yue, Ziyuan Gao, et al.
Antiviral Therapy|January 24, 2014
A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infectionFumitaka Suzuki, Joji Toyota, Kenji Ikeda, et al.
Antiviral Therapy|January 24, 2014
Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1Namiki Izumi, Osamu Yokosuka, Norifumi Kawada, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 22, 2013
Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis BRobert Perrillo, Maria Buti, Francois Durand, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
A practical method to calibrate self-reported adherence to antiretroviral therapyHonghu Liu, Loren G Miller, Ron D Hays, et al.
Journal of Hepatology|November 28, 2012
Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment optionsYoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki, et al.
Science Bulletin|April 2, 2025
Intrinsic ion migration-induced susceptible two-dimensional phase-transition memristor with ultralow power consumptionLanhao Qin, Yimeng Yu, Cheng Fang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 19, 2024
Intrinsic Defect-Driven Synergistic Synaptic Heterostructures for Gate-Free Neuromorphic PhototransistorsYao Deng, Shenghong Liu, Xiaoxi Ma, et al.
Journal of Gastroenterology and Hepatology|August 8, 2015
Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patientsHiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Journal of Gastroenterology|August 10, 2016
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infectionJoji Toyota, Yoshiyasu Karino, Fumitaka Suzuki, et al.
Pageof 5